(Q48654498)

13 February 2018

title

Neurotoxic consequences of central long-term administration of interleukin-2 in rats (English)

1 reference

13 February 2018

1 reference

7

Quirion R

1 reference

13 February 2018

author name string

Hanisch UK

1

1 reference

13 February 2018

Neuhaus J

2

1 reference

13 February 2018

Rowe W

3

1 reference

13 February 2018

Van Rossum D

4

1 reference

13 February 2018

Möller T

5

1 reference

13 February 2018

Kettenmann H

6

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

13 February 2018

number of pages

20

1 reference

inferred from page(s)

published in

Neuroscience

1 reference

13 February 2018

volume

79

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

799-818

1 reference

13 February 2018

Early response of brain resident microglia to kainic acid-induced hippocampal lesions

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of interleukin-2 in islet beta cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Cholinergic markers in aged cognitively impaired Long-Evans rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Cytotoxicity of microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

The interleukins-1 alpha, -1 beta, and -2 do not acutely disrupt the murine blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Stimulation of oligodendroglial proliferation and maturation by interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Transient focal neurologic deficits complicating interleukin-2 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2 enhances scopolamine-induced amnesia and hyperactivity in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin 2 modifies the bioelectric activity of some neurosecretory nuclei in the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Characterization of normal brain-reactive antibodies in glioma cyst fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Cellular forms and functions of brain microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Effects of pertussis toxin, dibutyryl-cyclic-AMP, bromo-cyclic-AMP and forskolin on the behavioural and electrocortical power spectrum changes induced by microinfusion of interleukin-2 into the locus coeruleus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

The neuroendocrine effects of interleukin-2 treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

An anatomical study of cholinergic innervation in rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Molecular profile of reactive astrocytes--implications for their role in neurologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Recovery of visual response of injured adult rat optic nerves treated with transglutaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Identification of an interleukin 2-like substance as a factor cytotoxic to oligodendrocytes and associated with central nervous system regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2 transcripts in human and rodent brains: possible expression by astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Capillary leak syndrome associated with elevated IL-2 serum levels after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Autoimmunity as a complication of interleukin 2 immunotherapy. Many unanswered questions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Cortical projection patterns of the medial septum-diagonal band complex

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Microglia: Intrinsic immuneffector cell of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Reactive glia as rivals in regulating neuronal survival

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

The impact of microglia-derived cytokines upon gliosis in the CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-1 is an astroglial growth factor in the developing brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2 as a neuroregulatory cytokine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Muscarinic cholinergic receptor binding in rat hindlimb somatosensory cortex following partial deafferentation by sciatic nerve transection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Phasic hyperactivity of the HPA axis resulting from chronic central IL-2 administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Autoimmune diabetes as a consequence of locally produced interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Local modulation of hippocampal acetylcholine release by dopamine D1 receptors: a combined receptor autoradiography and in vivo dialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2 stimulates the secretion of arginine vasopressin but not corticotropin-releasing hormone from rat hypothalamic cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Cytokines and the nervous system. I: Expression and recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Circulating autoantibody to mature neurons and astrocytes of humans and some mammals present in a demented patient with autoimmune disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Anterior pituitary hormone control by interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

The immunolocalisation of the neuroendocrine specific protein PGP9.5 during neurogenesis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

A role for interleukin-2 in the regulation of striatal dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Immunoautoradiographic localization of interleukin 2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Induction by cytokines of the pattern of pituitary hormone secretion in infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Adoptive immunotherapy of intracerebral metastases in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Delayed neurotoxicity of intraventricular interleukin-2: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Effect of chronic treatment with recombinant interleukin-2 on the central nervous system of adult and old mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2-like activity in injured rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Behavioral and Electrocortical Spectrum Power Effects after Microinfusion of Lymphokines in Several Areas of the Rat Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Cytokine receptors on glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Molecular cloning of IL-2R alpha, IL-2R beta, and IL-2R gamma cDNAs from a human oligodendroglioma cell line: presence of IL-2R mRNAs in the human central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin 2 suppresses afferent sensory transmission in the primary somatosensory cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Molecular cloning of a partial cDNA of the interleukin-2 receptor-beta in normal mouse brain: in situ localization in the hippocampus and expression by neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2 modulates calcium currents in dissociated hippocampal CA1 neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Arginine vasopressin release by acetylcholine or norepinephrine: region-specific and cytokine-specific regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Cytokines and the nervous system II: Actions and mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Involvement of cytokines in acute neurodegeneration in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

The effect of intravenous interleukin-2 on brain water content

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Treatment of murine primary brain tumors with systemic interleukin-2 and tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Induction of functional interleukin-2 receptor in mouse microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Lymphokines in autoimmunity--a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Systemic interleukin-1 alpha and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormone in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

In vivo modulation of myelin gene expression by human recombinant IL-2

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2 enhances the viability of primary cultured rat neocortical neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Studies of neuroimmune markers in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2 induction of ACTH secretion: presence of an interleukin-2 receptor alpha-chain-like molecule on pituitary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Macrophages and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Cytokine signaling through nonreceptor protein tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin 2 and its receptors: recent advances and new immunological functions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Electrophysiological studies of acetylcholine and the role of the basal forebrain in the somatosensory cortex of the cat. II. Cortical neurons excited by somatic stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Acute thyroid dysfunction (thyroiditis) after therapy with interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Fc receptor for IgG (FcR) on rat microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Clinical toxicity of interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2 does not cross the blood-brain barrier by a saturable transport system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

The IL-2/IL-2 receptor system: a target for rational immune intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Basal Forebrain Lesions with or without Reserpine Injection Inhibit Cortical Reorganization in Rat Hindpaw Primary Somatosensory Cortex following Sciatic Nerve Section

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Changes in plasma cytokines associated with peripheral nerve injury

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900040-7

7 January 2021

10.1016/S0306-4522(97)00040-7

Identifiers

DOI

1 reference

13 February 2018

release_6x6hwy3u6rbfdehplbvtyspgxq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6x6hwy3u6rbfdehplbvtyspgxq

24 November 2022

mapped directly with Wikidata item

1 reference

13 February 2018